INPPLPHARMA Stock Latest News
Company AnnouncementsPiramal Pharma Delivers Strong H1FY27 Performance and Upgrades Full-Year Outlook5d ago
Company AnnouncementsPiramal Pharma Posts Strong H1 FY27 Growth and Upgrades Full-Year Outlook5d ago
Company AnnouncementsPiramal Pharma Delivers Strong H1 FY27 and Upgrades Full-Year Outlook5d ago- Company AnnouncementsPiramal Pharma Appoints Viral Gandhi as Chief Technology Officer1M ago
- Company AnnouncementsPiramal Pharma to Appeal GST Order Confirming Rs 4.06 Crore Input Tax Credit Demand1M ago
Company AnnouncementsPiramal Pharma earns ‘Leader’ ESG rating from independent assessor1M agoCompany AnnouncementsPiramal Pharma Says Share Price Surge Driven by Market Dynamics, Not New Disclosures4M ago
Company AnnouncementsPiramal Pharma Receives FDA Form 483 With VAI Observations at U.S. Plant5M ago
Company AnnouncementsPiramal Pharma Posts FY26 Loss but Sees Recovery Momentum Across Key Businesses6M ago
Company AnnouncementsPiramal Pharma Clears FY26 Results and Strengthens Board, Governance Bench6M ago
Company AnnouncementsPiramal Pharma clears FY26 results and reinforces board continuity6M ago
Company AnnouncementsPiramal Pharma Clears FY26 Results and Confirms Continuity in Board Leadership6M ago
Company AnnouncementsPiramal Critical Care and Blue-Zone Partner to Recycle Waste Anaesthetic Gases8M ago
Company AnnouncementsPiramal Pharma to Acquire Kenalog Injectable Portfolio from Bristol-Myers Squibb9M ago
Company AnnouncementsPiramal Pharma Strengthens Senior Management, Appoints Interim Company Secretary9M ago
Company AnnouncementsPiramal Pharma Posts Higher Profit Despite Softer Revenue in Q3 FY269M ago
Company AnnouncementsPiramal Pharma Posts Muted Q3 FY26 Results but Signals Early Recovery and Continued Expansion9M ago
Company AnnouncementsPiramal Pharma Reshuffles Senior Management and Appoints Interim Company Secretary9M agoCompany AnnouncementsPiramal Pharma Posts Q3 Loss as CDMO Weakness Weighs, Signals Early Demand Recovery9M ago